Enoxacin in the treatment of Chlamydia trachomatis genitourinary infection.
Twenty women with Chlamydia trachomatis genitourinary infection were treated with oral enoxacin 800 mg/day in two divided doses for 12 days starting on day 1 of the menstrual cycle. A physical examination was performed before the start and 28-30 days after the end of the treatment. At the final examination cultures of urethral and endocervical swabs and endometrial samples were negative in all cases, demonstrating that Chlamydia trachomatis infection had been eradicated. No significant results were obtained at serologic evaluation with the indirect immunofluorescence method to show specific IgM, IgG and IgA antibodies. In the four women with subjective symptomatology this was improved by the treatment with enoxacin. Only two patients presented mild side effects (headache, tachycardia, nausea). Enoxacin seems therefore a very effective and well tolerated drug in the treatment of Chlamydia trachomatis genitourinary infection.
Fedele
L
L
1st Department of Obstetrics and Gynecology, Milan University, Italy.
Caravelli
E
E
Acaia
B
B
Bizioli
B
B
Dal Pra
M L
ML
Garlaschi
C
C
D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis / Q000276:immunology; D004717:Endometrium / Q000382:microbiology; D015365:Enoxacin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D052776:Female Urogenital Diseases / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D014522:Urethral Diseases / Q000382:microbiology; D002577:Uterine Cervical Diseases / Q000382:microbiology
D000907:Antibodies, Bacterial; D015365:Enoxacin